Increased risk of lipodystrophy when nucleoside analogue reverse transcriptase inhibitors are included with protease inhibitors in the treatment of HIV-1 infection (Q43517221)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | Increased risk of lipodystrophy when nucleoside analogue reverse transcriptase inhibitors are included with protease inhibitors in the treatment of HIV-1 infection |
scientific article |
Statements
1 reference
Increased risk of lipodystrophy when nucleoside analogue reverse transcriptase inhibitors are included with protease inhibitors in the treatment of HIV-1 infection (English)
1 reference
P Reiss
1 reference
M van der Valk
1 reference
E H Gisolf
1 reference
F W Wit
1 reference
A Japour
1 reference
G J Weverling
1 reference
S A Danner
1 reference
Prometheus study group
1 reference
1 May 2001
1 reference
Identifiers
1 reference